azides has been researched along with anthralin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baker, ND; Griffin, RJ; Irwin, WJ; Reichert, U; Schmidt, R | 1 |
| Benes, P; Benz, RE; Färber, L; Langendorf, Y; Schopf, RE | 1 |
1 trial(s) available for azides and anthralin
| Article | Year |
|---|---|
A highly decreased binding of cyclic adenosine monophosphate to protein kinase A in erythrocyte membranes is specific for active psoriasis.
Topics: Administration, Topical; Adolescent; Adult; Affinity Labels; Aged; Anthralin; Anti-Inflammatory Agents; Azides; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclosporine; Dermatologic Agents; Erythrocyte Membrane; Etretinate; Female; Humans; Keratolytic Agents; Male; Middle Aged; Protein Binding; Psoriasis; Retinoids; Severity of Illness Index | 2002 |
1 other study(ies) available for azides and anthralin
| Article | Year |
|---|---|
Uptake, cytotoxicity and metabolism of m-azidopyrimethamine and related lipophilic antifolates in SV-K14 human keratinocytes in vivo.
Topics: Animals; Anthralin; Azides; Cell Division; Cell Line, Transformed; Cell Survival; Culture Media; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Folic Acid Antagonists; Humans; In Vitro Techniques; Keratinocytes; Liver; Methotrexate; Mice; Mice, Hairless; Pyrimethamine; Regression Analysis; Skin | 1991 |